Synthetic vs. natural nicotine: which hits harder?

NCT ID NCT05962229

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how the body handles synthetic nicotine compared to natural nicotine from tobacco. Eighteen experienced e-cigarette users will vape three different nicotine blends in a controlled setting. Researchers will measure nicotine levels in the blood, heart effects, cravings, and how much people vape. The goal is to see if synthetic nicotine acts differently, which could matter for regulation and product safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
synthetic nicotine (R-nicotine and S-nicotine) in e-liquid
What this could lead to
If successful, this could help regulators understand whether synthetic nicotine behaves differently from natural nicotine, potentially informing future policies on e-cigarette ingredients.
What could go wrong
This is a very small, early-phase study with only 18 participants, so results may not apply to the general population. It measures short-term effects only, not long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NICOTINE DEPENDENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zuckerberg San Francisco General Hospital (ZSFG)

    RECRUITING

    San Francisco, California, 94110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.